Skip to main content
HR 1362 116th Congress House Health Appropriations Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Licensing and registrations User charges and fees

Medical Innovation Never Stops Act of 2019

Introduced: February 26, 2019 Introduced by: Emmer, Tom Republican · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2019
Referred to the Subcommittee on Health.
Feb 26, 2019
Referred to the House Committee on Energy and Commerce.
Feb 26, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Medical Innovation Never Stops Act of 2019

This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.

What's happening now February 27, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2